Italia markets close in 7 hours 44 minutes

NPCE Jul 2024 10.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,41000,0000 (0,00%)
In data: 12:55PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,4100
Aperto0,4100
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio10,00
Scadenza2024-07-19
Min-Max giorno0,4100 - 0,4100
Contratto - Min-MaxN/D
Volume1
Open InterestN/D
  • GlobeNewswire

    NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference

    MOUNTAIN VIEW, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced participation in a fireside chat discussion at the upcoming 2023 Cantor Fitzgerald Global Healthcare Conference on Thursday, September 28, 2023, at 1:15 p.m. ET in New York, New York. A live webcast of the Cantor Fitzgerald discussion can be accessed through the Events & Presentations

  • GlobeNewswire

    NeuroPace to Participate in Upcoming Investor Conferences

    - Wells Fargo 2023 Healthcare Conference - - Morgan Stanley 21st Annual Global Healthcare Conference - - Lake Street Capital Markets 7th Annual Best Ideas Growth Conference - MOUNTAIN VIEW, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced its participation in the following upcoming investor conferences: Management will host 1x1 meetings at the Wells

  • GlobeNewswire

    NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

    Second quarter 2023 revenue of $16.5 million increased 62% year-over-year Full-year revenue guidance increased to $59-$61 million, up from $52-54 million Cash burn reduced to $4 million in the second quarter of 2023, relative to $9.8 million in the first quarter of 2023 MOUNTAIN VIEW, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today reported financial results